Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
Molecule | Cat. No. | Species | Product Description | Host | Structure | Purity | Feature | Size&Price | Compare |
CLEC12A |
CLA-H82F7
Avitag
|
![]() |
Biotinylated Human CLEC12A / MICL / CLL-1 Protein, Fc,Avitag™ | HEK293 |
![]() |
![]() ![]() |
![]() ![]() ![]() ![]() |
![]() |
|
CLEC12A | CLA-HP2H4 |
![]() |
PE-Labeled Human CLEC12A / MICL / CLL-1 Protein, His Tag (C-terminus) (Site-specific conjugation) | HEK293 |
![]() |
![]() ![]() |
![]() |
||
CLEC12A | CLA-HA246 |
![]() |
APC-Labeled Human CLEC12A / MICL / CLL-1 Protein, His Tag, premium grade (Site-specific conjugation) | HEK293 |
![]() |
![]() ![]() |
![]() |
||
CLEC12A | CLA-H5266 |
![]() |
Human CLEC12A / MICL / CLL-1 Protein, Fc Tag (MALS verified) | HEK293 |
![]() |
![]() ![]() ![]() ![]() |
![]() ![]() ![]() ![]() |
![]() |
|
CLEC12A | CLA-M5244 |
![]() |
Mouse CLEC12A / MICL / CLL-1 Protein, His Tag | HEK293 |
![]() |
![]() ![]() |
![]() |
||
CLEC12A | CLA-R5248 |
![]() |
Rat CLEC12A / MICL / CLL-1 Protein, His Tag | HEK293 |
![]() |
![]() ![]() |
![]() |
||
CLEC12A | CLA-C5246 |
![]() |
Cynomolgus CLEC12A / MICL / CLL-1 Protein, His Tag | HEK293 |
![]() |
![]() ![]() |
![]() |
Cat. No. | Product Description | Size&Price | Compare |
EP-138 | CD47 [Biotinylated] : SIRP alpha Inhibitor Screening ELISA Kit |
![]() |
|
EP-160 | CD47 : SIRP gamma [Biotinylated] Inhibitor Screening ELISA Kit |
![]() |
Cat. No. | Product Description | Size&Price | Compare |
MBS-K080 | APC-labeled Human CD47-coupled Magnetic Beads |
![]() |
|
MBS-K023 | Human CD47-coupled Magnetic Beads |
![]() |
|
MBS-K059 | PE-labeled Human CD47-coupled Magnetic Beads |
![]() |
Project Name | Modality | Therapeutic Area | Indications | Stage | Right Available |
CD47 Monoclonal Antibody | Monospecific antibody | Oncology/Cancer | Advanced solid tumor,Advanced hematological tumor | IND | Global |
This web search service is supported by Google Inc.